Aptuit competitors

Zippia score 4.3

Aptuit main competitors are Catalyst Biosciences, Watson Pharma Pvt Ltd, and Wyeth Biopharma.

Competitor Summary. See how Aptuit compares to its main competitors:

Wyeth Biopharma has the most employees (49,732).
Employees at Catalyst Biosciences earn more than most of the competitors, with an average yearly salary of $84,389.

Work at Aptuit?

Share your experience

Aptuit vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Aptuit	2004	4.3	Greenwich, CT	1	$100.0M	1,733
Irisys	1966	3.6	San Diego, CA	1	$3.0M	63
XenoPort, Inc.	-	4.5	Santa Clara, CA	1	$41.2M	200
Turning Point Therapeutics	2013	4.2	San Diego, CA	1	$25.0M	142
DPT Laboratories	1938	4.9	San Antonio, TX	1	$320.0M	510
EMD Millipore	1954	4.8	Billerica, MA	1	$7.2B	6,100
Catalyst Biosciences	1997	4.4	South San Francisco, CA	2	$105.8M	21
Mylan	1961	4.8	Canonsburg, PA	2	$11.5B	35,000
Paddock Laboratories	1977	4.3	Minneapolis, MN	1	$100.5M	51
Mallinckrodt	1867	4.8	Hazelwood, MO	5	$1.0B	3,400
Catalent Pharma Solutions	2007	4.4	Somerset, NJ	14	$4.4B	14,000
Watson Pharma Pvt Ltd	1984	4.9	Parsippany-Troy Hills, NJ	1	$5.9B	21,600
Par Pharmaceutical Inc	2003	4.9	Spring Valley, NY	4	$260.0M	400
Sun Pharmaceutical Industries Inc.	1984	4.6	Cranbury, NJ	3	$4.2B	32,000
CorePharma	1995	4.3	Middlesex, NJ	1	$15.0M	200
Watson Laboratories	1992	4.4	Corona, CA	1	$37.0M	50
Pliva	1979	4.2	East Hanover, NJ	1	$1.2B	1,700
Wyeth Biopharma	1860	4.7	Madison, NJ	1	$22.4B	49,732
DSM Pharmaceuticals Inc	1993	4.7	Greenville, NC	1	$850.0M	1,200
Quidel	1979	4.7	San Diego, CA	3	$1.7B	1,500
Coldstream Labs	2007	4.2	Lexington, KY	1	$3.5M	50

Rate Aptuit's competitiveness in the market.

Aptuit salaries vs competitors

Among Aptuit competitors, employees at Catalyst Biosciences earn the most with an average yearly salary of $84,389.

Compare Aptuit salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Aptuit	$66,558	$32.00	-
Irisys	$65,543	$31.51	-
Turning Point Therapeutics	$54,113	$26.02	-
DPT Laboratories	$58,092	$27.93	-
EMD Millipore	$60,972	$29.31	-
Catalyst Biosciences	$84,389	$40.57	-

Compare Aptuit job title salaries vs competitors

Company	Highest salary	Hourly salary
Aptuit	$72,854	$35.03
Quidel	$124,127	$59.68
Watson Pharma Pvt Ltd	$122,699	$58.99
Wyeth Biopharma	$101,280	$48.69
Mallinckrodt	$96,283	$46.29
Sun Pharmaceutical Industries Inc.	$86,039	$41.37
Mylan	$78,553	$37.77
Paddock Laboratories	$77,063	$37.05
Par Pharmaceutical Inc	$76,496	$36.78
Catalent Pharma Solutions	$75,034	$36.07
EMD Millipore	$74,656	$35.89
Watson Laboratories	$73,535	$35.35
DSM Pharmaceuticals Inc	$71,935	$34.58
Coldstream Labs	$71,837	$34.54
Pliva	$71,640	$34.44
CorePharma	$71,401	$34.33
Irisys	$70,075	$33.69
DPT Laboratories	$70,010	$33.66
Catalyst Biosciences	$65,263	$31.38
XenoPort, Inc.	$64,537	$31.03

Do you work at Aptuit?

Is Aptuit able to compete effectively with similar companies?

Aptuit jobs

Aptuit demographics vs competitors

Compare gender at Aptuit vs competitors

Job title	Male	Female
DSM Pharmaceuticals Inc	54%	46%
Catalyst Biosciences	54%	46%
Catalent Pharma Solutions	57%	43%
EMD Millipore	57%	43%
Quidel	58%	42%
Aptuit	-	-

Male

Female

100%

75%

50%

25%

Aptuit

Quidel

EMD Millipore

Catalent Pharma Solutions

Catalyst Biosciences

DSM Pharmaceuticals Inc

25%

50%

75%

100%

Compare race at Aptuit vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Catalent Pharma Solutions	60%	16%	10%	9%	4%	9.7
Catalyst Biosciences	29%	25%	4%	36%	6%	7.1
Quidel	50%	24%	8%	14%	5%	9.8
DSM Pharmaceuticals Inc	60%	12%	16%	9%	4%	8.9
EMD Millipore	62%	14%	6%	15%	3%	9.8
Mylan	62%	18%	7%	10%	3%	9.3

Aptuit and similar companies CEOs

CEOBio

Nassim Usman

Catalyst Biosciences

Experienced Chief Executive Officer with a demonstrated history of working in the biotechnology industry. Skilled in Life Sciences Research & Development (R&D), Strategy, Financing, Business Development & Entrepreneurship.

Douglas C. Bryant

Quidel

Douglas C. Bryant became President and Chief Executive Officer on March 1, 2009. Prior to joining Quidel, Mr. Bryant served as Executive Vice President and Chief Operating Officer at Luminex Corporation, managing its Bioscience Group, Luminex Molecular Diagnostics (Toronto), manufacturing, R&D, technical operations, and commercial operations. From 1983 to 2007, he held various worldwide commercial operations positions with Abbott Laboratories including, among others: Vice President of Abbott Vascular for Asia/Japan, Vice President of Abbott Molecular Global Commercial Operations and Vice President of Abbott Diagnostics Global Commercial Operations. Earlier in his career with Abbott, Mr. Bryant was Vice President of Diagnostic Operations in Europe, the Middle East and Africa, and Vice President of Diagnostic Operations Asia Pacific. Mr. Bryant holds a B.A. in Economics from the University of California at Davis.

Mark Trudeau

Mallinckrodt

Heather Bresch

Mylan

Heather Manchin Bresch (Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list.

Abhay Gandhi

Sun Pharmaceutical Industries Inc.

Bernard Poussot

Wyeth Biopharma

Arpit Patel

CorePharma

Arpit Patel is an Associate Director, Quality Assurance and Compliance at Aurolife Pharma LLC and Chief Executive Officer & Board Member at CorePharma LLC and is based in Dayton, New Jersey. He has worked as Quality Engineer, Quality Compliance at 29 Consulting LLC - Vascular Therapies, Inc; Quality Assurance Consultant at CorePharma LLC; and Acting Director, Quality Assurance and Compliance at Aurolife Pharma LLC. Arpit attended Fairleigh Dickinson University-Metropolitan Campus between 2007 and 2009; Gujarat University, L M College of Pharmacy; and Telnet between 2002 and 2006.

Gerald J. Yakatan

Irisys

Eric Smart

Coldstream Labs